Hallucinogen
Showing 1 - 25 of 37
Healthy Trial in London (Lysergic Acid Diethylamide (LSD) 50µg, Lysergic Acid Diethylamide (LSD) 75µg, Lysergic Acid
Completed
- Healthy
- Lysergic Acid Diethylamide (LSD) 50µg
- +4 more
-
London, United KingdomPAREXEL, Early Phase Clinical Unit
Jan 5, 2023
Stroke Trial in Leiden (N,N-Dimethyltryptamine, Placebo)
Recruiting
- Stroke
- N,N-Dimethyltryptamine
- Placebo
-
Leiden, NetherlandsCentre for Human Drug Research
Jan 30, 2023
Healthy Trial in Basel (Lysergic Acid Diethylamide, Ketanserin Placebo, Ketanserin)
Completed
- Healthy
- Lysergic Acid Diethylamide
- +2 more
-
Basel, SwitzerlandClinical Pharmacology & Toxicology, University Hospital Basel
Oct 20, 2021
Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)
Not yet recruiting
- Basic Science
- Lysergic Acid Diethylamide Tartrate
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Jul 11, 2023
Entheogen Resurgence
Completed
- Psychedelic Experiences
- self-reported entheogen use
-
Queens, New YorkVireo Health of New York
Jan 26, 2022
Major Depression, Post Traumatic Stress Disorder Trial in Seattle (SM-001)
Not yet recruiting
- Major Depression
- Post Traumatic Stress Disorder
-
Seattle, WashingtonAIMS Institute
Jun 13, 2023
Post-Treatment Lyme Disease, Chronic Lyme Disease, Lyme Disease, Chronic Trial in Baltimore (Psilocybin)
Enrolling by invitation
- Post-Treatment Lyme Disease
- +2 more
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Aug 2, 2022
Safety Issues, Healthy Volunteers Trial in Natal (N,N-Dimethyltryptamine, Placebo)
Recruiting
- Safety Issues
- Healthy Volunteers
- N,N-Dimethyltryptamine
- Placebo
-
Natal, RN, BrazilHospital Universitário Onofre Lopes
Jun 2, 2023
Depressive Symptoms, Depression, Alzheimer Trial in Baltimore (Psilocybin)
Recruiting
- Depressive Symptoms
- +3 more
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Mar 9, 2022
Healthy Volunteers Trial in Natal (N,N-Dimethyltryptamine)
Completed
- Healthy Volunteers
-
Natal, Rio Grande Do Norte, BrazilHospital Universitário Onofre Lopes
Nov 21, 2022
Cluster Headache Trial in Basel (Lysergic Acid Diethylamide, Placebo)
Recruiting
- Cluster Headache
- Lysergic Acid Diethylamide
- Placebo
-
Basel, SwitzerlandClinical Pharmacology & Toxicology, University Hospital Basel
May 4, 2022
Healthy Trial in Basel (Placebo, Mescaline 100mg, Mescaline 200mg)
Recruiting
- Healthy
- Placebo
- +5 more
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Clinical Trial Unit
Aug 17, 2021
Prescription Drug Abuse (Not Dependent), Intentional Misuse Trial in Hartford, San Marcos, Laramie (Web-based presentation,
Recruiting
- Prescription Drug Abuse (Not Dependent)
- Intentional Misuse
- Web-based placebo presentation
- Web-based simulation active intervention
-
Hartford, Connecticut
- +2 more
Apr 1, 2022
Healthy Trial in Basel (Escitalopram, Placebo oral capsule)
Completed
- Healthy
- Escitalopram
- Placebo oral capsule
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Clinical Trial Unit
Nov 30, 2020
MDD Trial in Eatontown (CYB003, Psychotherapy, Placebo)
Recruiting
- Major Depressive Disorder
- CYB003
- +2 more
-
Eatontown, New JerseyClinilabs Drug Development Corporation
Jul 11, 2022
Alcohol Use Disorder Trial in Santa Monica (Psilocybin plus Visual Healing Set and Setting, Psilocybin plus Standard Set and
Active, not recruiting
- Alcohol Use Disorder
- Psilocybin plus Visual Healing Set and Setting
- Psilocybin plus Standard Set and Setting
-
Santa Monica, CaliforniaPacific Treatment & Research in Psychedelics
Jan 28, 2022
Healthy Trial in Basel (Lysergic Acid Diethylamide, 3,4-methylenedioxymethamphetamine, LSD Placebo)
Recruiting
- Healthy
- Lysergic Acid Diethylamide
- +3 more
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Clinical Trial Unit
Sep 6, 2021
Acute Pain, Burns, Adverse Drug Event Trial (Oliceridine, Historical opioid use)
Not yet recruiting
- Acute Pain
- +4 more
- Oliceridine
- Historical opioid use
- (no location specified)
Jul 25, 2022
Treatment Resistant Depression Trial in Mississauga (Psilocybin)
Active, not recruiting
- Treatment Resistant Depression
-
Mississauga, Ontario, CanadaCanadian Rapid Treatment Centre of Excellence (CRTCE)
Mar 2, 2022
Depressive Disorder, Major Trial in United States (Esketamine, Aripiprazole)
Not yet recruiting
- Depressive Disorder, Major
-
Tuscaloosa, Alabama
- +26 more
Sep 21, 2022
Drug Effect Trial in Baltimore (Salvinorin A)
Completed
- Drug Effect
- Salvinorin A
-
Baltimore, MarylandBehavioral Pharmacology Research Unit, Johns Hopkins Bayview Med
Feb 11, 2021
Illness Terminal Trial (Ketamine Injectable Solution, Naturalistic Control)
Not yet recruiting
- Illness Terminal
- Ketamine Injectable Solution
- Naturalistic Control
- (no location specified)
Feb 22, 2022
Depressive Symptoms Trial in Eugene (Group-based therapy)
Completed
- Depressive Symptoms
- Group-based therapy
-
Eugene, OregonOregon Research Institute
Sep 14, 2020